Related Experiment Videos
Fibrodysplasia ossificans progressiva: case report
A Nucci1, L D Queiroz, A D Santos
1Department of Neurology, Faculty of Medicine, State University of Campinas (UNICAMP), SP, Brasil.
Arquivos De Neuro-Psiquiatria
|June 13, 2000
Summary
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder causing bone to form in soft tissues. This case study details a decade-long FOP progression in a child, highlighting challenges in management and treatment.
Area of Science:
- Medical Genetics
- Rare Diseases
- Pediatric Orthopedics
Background:
- Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by progressive heterotopic ossification of soft tissues.
- Congenital malformations, such as hypoplastic hallux valgus and cardiac defects, are often associated with FOP.
- Early diagnosis and long-term monitoring are crucial for managing FOP.
Observation:
- A male patient diagnosed with FOP at age 3 years and 9 months was followed for ten years.
- The patient presented with bilateral hypoplastic hallux valgus and a ventricular septal defect, which was surgically corrected.
- Progressive ossification led to restricted neck and chest wall mobility, with four exacerbation crises managed by anti-inflammatory drugs and intermittent bisphosphonate therapy.
Findings:
- The disease course was relentless despite treatment with prednisone, anti-inflammatory drugs, and sodium etidronate.
- Sodium etidronate was discontinued due to the development of osteopenia.
- Severe movement restriction, including the chest wall, significantly impacted the patient's quality of life.
Implications:
- This case underscores the aggressive nature of FOP and the limited efficacy of current treatments.
- Management strategies require careful consideration of potential side effects, such as osteopenia from bisphosphonates.
- Further research into novel therapeutic approaches for FOP is essential to improve patient outcomes.